Health
A conversation with the eminent scientist Roland Griffiths about the importance of studying psychedelics and transformative experiences.
A research partnership between the University of California San Francisco and the Fireside Project peer-support hotline reveals insights into psychedelic harm reduction.
MDMA and LSD may be a beneficial combination for patients who have never taken psychedelics and are frightened, suggests one researcher.
A new study suggests that psychedelics may have the ability to unlock limited time spans of learning called “critical periods,” which are the only chance to learn certain behaviors.
Psychedelic users are skeptical of information from governments and pharma companies, consider popular media inaccurate, but learn from their own experiences and from friends.
A team of researchers in Brazil is investigating ayahuasca as a possible therapeutic treatment for depression and determining the impact of the psychedelic effect.
The owner of the state’s first psilocybin service center to receive a license speaks about the lengthy path to approval.
The scientist whose pivotal studies set in motion a renaissance in psychedelic research, points the way forward while reflecting on his own mortality.
Psychedelics are safe for healthy older adults, a new review of clinical trials suggests, but few are included in research studies.
The treatment, developed by Awakn Life Science, was administered today in New York City at the Nushama ketamine clinic.
